Evidence map›Paper›PMID 35844621›Full record

ArticleFrontiers in immunology2022

CXCR6

Kevin Aviles-Padilla, Laura S Angelo, Dwight Fan, Silke Paust

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kevin Aviles-PadillaCenter for Human Immunobiology, Department of Pediatrics, Texas Children's Hospital, Houston, TX, United States.
Laura S AngeloCenter for Human Immunobiology, Department of Pediatrics, Texas Children's Hospital, Houston, TX, United States.
Dwight FanCenter for Human Immunobiology, Department of Pediatrics, Texas Children's Hospital, Houston, TX, United States.
Silke PaustCenter for Human Immunobiology, Department of Pediatrics, Texas Children's Hospital, Houston, TX, United States.
Rice University · USTexas Children's Hospital · US

Funding

How antigen exposure shapes the subsequent NK cell response to HIVR01AI161014 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI PAUST, SILKE · 2021 to 2025
$4.2M
Harnessing NK Memory To Protect Against HIV InfectionR01AI116282 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI PAUST, SILKE · 2015 to 2019
$3.2M
NIAID NIH HHS R01 AI116282NIAID NIH HHS R01 AI161014
6 · The paper itself

Abstract

Reactivation of human cytomegalovirus (HCMV) is a life-threatening complication in transplant patients. Natural Killer (NK) cells are the first lymphocyte lineage to reconstitute following an allogeneic hematopoietic stem cell transplant (HSCT). Amongst them, NK cell Group 2 isoform C/Killer cell lectin-like receptor subfamily C, member 2 (NKG2C)-expressing NK cells contribute significantly to patient protection upon HCMV reactivation. NKG2C

Indexed as

Bone Marrow TransplantationNK Cell Lectin-Like Receptor Subfamily CAnimalsChildCytomegalovirusHumansKiller Cells, NaturalMicePhenotypeReceptors, CXCR6ViremiaCXCR6 protein, humanCxcr6 protein, mouseNK Cell Lectin-Like Receptor Subfamily CReceptors, CXCR6bone marrow transplantationCXCR6hematopoietic stem cell transplantationhuman cytomegalovirusnatural killer cellNKG2C

Identifiers

PMID35844621
PMCPMC9277058
OpenAlexW4283701055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.